Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma

被引：32

作者：

Bassiouny, Dina ^{[1
,2
,3
]}

Ismiil, Nadia ^{[1
,2
]}

Dube, Valerie ^{[1
,2
]}

Han, Guangming ^{[1
,2
]}

Cesari, Matthew ^{[1
,2
]}

Lu, Fang-I ^{[1
,2
]}

Slodkowska, Elzbieta ^{[1
,2
]}

Parra-Herran, Carlos ^{[1
,2
]}

Chiu, Hak Fai ^{[1
]}

Naeim, Magda ^{[1
]}

Li, Nim ^{[1
]}

Khalifa, Mahmoud ^{[1
,2
]}

Nofech-Mozes, Sharon ^{[1
,2
]}

机构：

[1] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[2] Univ Toronto, Toronto, ON, Canada

[3] Mansoura Univ, Mansoura, Egypt

来源：

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2018年 / 26卷 / 04期

关键词：

ovarian cancer; mucinous; immunohistochemistry; SATB2; HER2; PAX8; napsin A; HNFlb; LYMPH-NODE METASTASIS; CLEAR-CELL CARCINOMA; DIFFERENTIAL-DIAGNOSIS; ENDOMETRIOID CARCINOMA; TUMOR-SUPPRESSOR; SATB2; EXPRESSION; LYNCH SYNDROME; BREAST-CANCER; ARID1A; ADENOCARCINOMA;

D O I：

10.1177/1066896917752861

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

The distinction of primary mucinous ovarian carcinoma (PMOC) from other primaries or secondaries is essential for selecting therapeutic options and prognostication. We aimed to characterize the immunohistochemical profile of 36 PMOCs using an extended immunohistochemical panel, with clinicopathologic features and outcome. PAX8 was negative in 30 (83.3%), and SATB2 was negative in 32/35. HNF1B, AMACR, and napsin-A were detected in 33 (91.7%), 35 (97.2%), and 0 (0%), respectively. MMR proteins and ARID1A were retained in 100%; PTEN was lost in 4 (11.1%). P53 was aberrant in 10 (27.8%); none overexpressed p16. HER2 was positive in 6/35 (17.1%). Most PMOCs had a favorable outcome. However, recurrence is usually fatal. The typical tumor profile was CK7+, CK20+/-, CDX2+/-, PAX8-, ER-, PgR-, and SATB2-. HER2 positivity suggests a possible target for therapy in advanced disease.

引用

页码：306 / 317

页数：12

共 50 条

[21] Mucinous Ovarian Carcinoma
Hackshaw, Allan
Gershenson, David
Ledermann, Jonathan
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01):
[22] Mucinous Ovarian Carcinoma
不详
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (09) : 530 - 532
[23] Thymic carcinoma arising in thymoma: A clinicopathologic study with immunohistochemical characterization
Kuo, T
Chan, JKC
MODERN PATHOLOGY, 1998, 11 (01) : 177A - 177A
[24] Mucinous Ovarian Carcinoma
Morice, Philippe
Gouy, Sebastien
Leary, Alexandra
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13): : 1256 - 1266
[25] Clinicopathologic and Immunohistochemical Characterization of Primary Gastrointestinal Tract Neuroendocrine Carcinomas
Chen, Irene
Zhang, Dongwei
Velez, Moises
Kovar, Sierra
Liao, Xiaoyan
MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 391 - 392
[26] Clinicopathologic and Immunohistochemical Characterization of Primary Gastrointestinal Tract Neuroendocrine Carcinomas
Chen, Irene
Zhang, Dongwei
Velez, Moises
Kovar, Sierra
Liao, Xiaoyan
LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 391 - 392
[27] Mucinous carcinoma of the ovary - Clinicopathologic analysis
Kikkawa, F
Kawai, M
Tamakoshi, K
Suganuma, N
Nakashima, N
Furuhashi, Y
Kuzuya, K
Hattori, S
Arii, Y
Tomoda, Y
ONCOLOGY, 1996, 53 (04) : 303 - 307
[28] Cerebellar liponeurocytoma: An updated comprehensive review of clinicopathologic, immunohistochemical, and molecular features of an unusual but distinct tumor
Broggi, Giuseppe
Salzano, Serena
Mazzucchelli, Manuel
Rosano, Giovanni Nunzio
Magro, Gaetano
Caltabiano, Rosario
Barresi, Valeria
CLINICAL NEUROPATHOLOGY, 2025, 44 (01) : 26 - 36
[29] Clinicopathologic Characteristics of Mucinous Carcinoma of the Breast
Hanagiri, Takeshi
Ono, Kenji
Baba, Teturo
So, Tetsuya
Yamasaki, Masaharu
Nagata, Yoshika
Uramoto, Hidetaka
Takenoyama, Mitsuhiro
Yasumoto, Kosei
INTERNATIONAL SURGERY, 2010, 95 (02) : 126 - 129
[30] Clinicopathologic features of mucinous gastric carcinoma
Woo, LS
Kim, DY
Kim, YJ
Kim, SK
DIGESTIVE SURGERY, 2002, 19 (04) : 286 - 290

← 1 2 3 4 5 →